Filing Manager
PFM Health Sciences, LP
Reporting Manager
PFM Health Sciences, LP
Symbol
EPIX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:06:25 UTC
Date of event
31 Dec 2024

Quoteable Key Fact

"PFM Health Sciences, LP disclosed 0% ownership in ESSA Pharma Inc. Common Shares, no par value per share (the "Shares") (EPIX) on 31 Dec 2024."

Quick Takeaways

  • PFM Health Sciences, LP filed SCHEDULE 13G/A for ESSA Pharma Inc. Common Shares, no par value per share (the "Shares") (EPIX).
  • Disclosed ownership: 0%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:06.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
PFM Health Sciences, LP 0% 0 0 0 /s/ Darren Mooney Darren Mooney, Authorized Signatory
PFM Health Sciences GP, LLC 0% 0 0 0 /s/ Darren Mooney Darren Mooney, Authorized Signatory
Partner Asset Management, LLC 0% 0 0 0 /s/ Darren Mooney Darren Mooney, Authorized Signatory
Brian D. Grossman 0% 0 0 0 /s/ Darren Mooney Darren Mooney, attorney-in-fact*
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .